Fed: Stilnox to remain schedule four medicine

AAP General News (Australia)
02-21-2008
Fed: Stilnox to remain schedule four medicine

BRISBANE, Feb 21 AAP - Australia's medicines regulator, the Therapeutic Goods Administration
(TGA), has decided against re-classifying the controversial sleeping pill Stilnox, instead
ordering boxes to carry warnings.

The TGA's National Drugs and Poisons Schedule Committee today considered whether to
reschedule zolpidem, sold as Stilnox in Australia, to schedule eight, making it as difficult
to obtain as drugs such as rohypnol.

Zolpidem is currently a schedule four prescription medicine.

It follows reports of bizarre and sometimes dangerous …